|
98
|
256
|
4cfnB |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
72
|
263
|
4byiA |
Aurora a kinase bound to a highly selective imidazopyridine inhibitor |
|
165
|
487
|
4bzbA |
Crystal structure of the tetrameric dgtp-bound samhd1 mutant catalytic core |
|
235
|
716
|
4c50A |
Crystal structure of the catalase-peroxidase (katg) d137s mutant from mycobacterium tuberculosis |
|
47
|
171
|
4bvuA |
Structure of shigella effector ospg in complex with host ubch5c- ubiquitin conjugate |
|
20
|
69
|
4c2mJ |
Structure of rna polymerase i at 2.8 a resolution |
|
138
|
458
|
4ccjA |
60s ribosomal protein l8 histidine hydroxylase (no66) in apo form |
|
105
|
338
|
4c36A |
Pka-s6k1 chimera with compound 15e (cct147581) bound |
|
141
|
459
|
4ccoA |
60s ribosomal protein l8 histidine hydroxylase (no66 s373c) in complex with mn(ii), n-oxalylglycine (nog) and 60s ribosomal protein l8 (rpl8 g214c) peptide fragment (complex-3) |
|
94
|
308
|
4cnhA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-methoxyphenyl)ethoxy)-5-(1-methyl-1h- 1,2,3-triazol-5-yl)pyridin-2-amine |
|
93
|
290
|
4btkA |
Ttbk1 in complex with inhibitor |
|
77
|
279
|
4c4hA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
179
|
467
|
4cdnA |
Crystal structure of m. mazei photolyase with its in vivo reconstituted 8-hdf antenna chromophore |
|
87
|
268
|
4bw9A |
Pylrs y306g, y384f, i405r mutant in complex with amp-pnp |
|
137
|
408
|
4c9pA |
Structure of camphor bound t260a mutant of cyp101d1 |
|
86
|
223
|
4cf5A |
Mutagenesis of a rhodobacteraceae l-haloacid dehalogenase |
|
220
|
880
|
4b08A |
Yeast dna polymerase alpha, selenomethionine protein |
|
107
|
322
|
4c02A |
Crystal structure of human acvr1 (alk2) in complex with fkbp12.6 and dorsomorphin |
|
119
|
370
|
4bqqA |
Protein crystal structure of the n-terminal and recombinase domains of the streptomyces temperate phage serine recombinase, fc31 integrase. |
|
145
|
454
|
4btfA |
Structure of mlkl |
|
272
|
734
|
4b3jA |
Crystal structure of mycobacterium tuberculosis fatty acid beta- oxidation complex with coenzymea bound at the hydratase and thiolase active sites |
|
115
|
311
|
4bqnA |
Structural insights into wcbi, a novel polysaccharide biosynthesis enzyme. native protein. |
|
64
|
178
|
4by4A |
Crystal structure of drosophila frq2 |
|
157
|
449
|
4c28A |
Crystal structure of trypanosoma cruzi cyp51 bound to the inhibitor (r)-n-(3-(1h-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-4-(4-(4-chlorophenyl)piperazin-1-yl)-2-fluorobenzamide. |
|
98
|
308
|
4cd0A |
Structure of l1196m mutant human anaplastic lymphoma kinase in complex with 2-(5-(6-amino-5-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2- yl)phenyl)ethoxy)pyridin-3-yl)-4-methylthiazol-2-yl)propane-1,2-diol |
|
58
|
170
|
4bwcA |
X-ray structure of a phospholiapse b like protein 1 from bovine kidneys |
|
37
|
92
|
4c31B |
Nup1:sac3:sus1 complex |
|
128
|
325
|
4c1iA |
Selective inhibitors of pde2, pde9, and pde10: modulators of activity of the central nervous system |
|
110
|
291
|
4ccxA |
Altering substrate specificity at the heme edge of cytochrome c peroxidase |
|
88
|
301
|
4cfvA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
87
|
309
|
4c8bA |
Structure of the kinase domain of human ripk2 in complex with ponatinib |
|
104
|
327
|
4cfpA |
Crystal structure of mltc in complex with tetrasaccharide at 2.15 a resolution |
|
95
|
308
|
4cmtA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy)- 5-(3-(methylsulfonyl)phenyl)pyridin-2-amine |
|
95
|
292
|
4btjA |
Ttbk1 in complex with atp |
|
224
|
582
|
4bkeA |
Recombinant human serum albumin with palmitic acid. synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site ii of human serum albumin |
|
77
|
262
|
4c3rA |
Structure of dephosphorylated aurora a (122-403) bound to amppcp |
|
34
|
124
|
4ca0A |
Structural basis for the microtubule binding of the human kinetochore ska complex |
|
93
|
258
|
4cfmB |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
33
|
100
|
5f99D |
X-ray structure of the mmtv-a nucleosome core particle |
|
77
|
280
|
4c4gA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
208
|
583
|
4c3oA |
Structure and function of an oxygen tolerant nife hydrogenase from salmonella |
|
80
|
299
|
4cfxA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
144
|
448
|
4bmmA |
Crystal structure of trypanosoma cruzi cyp51 bound to the inhibitor (r)-n-(3-(1h-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-2',3, 5'-trifluoro-(1,1'-biphenyl)-4-carboxamide |
|
81
|
279
|
4c4eA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
97
|
264
|
4ci4A |
Structural basis for gl479 a dual peroxisome proliferator-activated receptor alpha agonist |
|
142
|
408
|
4bofA |
Crystal structure of arginine deiminase from group a streptococcus |
|
159
|
450
|
4c27A |
Crystal structure of trypanosoma cruzi cyp51 bound to the inhibitor (r)-n-(3-(1h-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-2-fluoro-4-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)benzamide |
|
166
|
486
|
4bzcA |
Crystal structure of the tetrameric dgtp-bound wild type samhd1 catalytic core |
|
249
|
945
|
4bfrA |
Discovery and optimization of pyrimidone indoline amide pi3kbeta inhibitors for the treatment of phosphatase and tensin homologue (pten)-deficient cancers |
|
72
|
196
|
4br6A |
Crystal structure of chaetomium thermophilum mnsod |
